These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35170269)

  • 21. Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection.
    Pérez-García F; Romanyk J; Gómez-Herruz P; Arroyo T; Pérez-Tanoira R; Linares M; Pérez Ranz I; Labrador Ballestero A; Moya Gutiérrez H; Ruiz-Álvarez MJ; Cuadros-González J
    J Clin Virol; 2021 Apr; 137():104781. PubMed ID: 33639492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Performance of Direct RT-PCR Testing of Raw Saliva for Detection of SARS-CoV-2 in Symptomatic and Asymptomatic Individuals.
    Castillo-Bravo R; Lucca N; Lai L; Marlborough K; Brychkova G; Sakhteh MS; Lonergan C; O'Grady J; Alikhan NF; Trotter AJ; Page AJ; Smyth B; McKeown PC; Feenstra JDM; Ulekleiv C; Sorel O; Gandhi M; Spillane C
    Microbiol Spectr; 2022 Dec; 10(6):e0222922. PubMed ID: 36409097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saliva for molecular detection of SARS-CoV-2 in school-age children.
    Al Suwaidi H; Senok A; Varghese R; Deesi Z; Khansaheb H; Pokasirakath S; Chacko B; Abufara I; Loney T; Alsheikh-Ali A
    Clin Microbiol Infect; 2021 Sep; 27(9):1330-1335. PubMed ID: 33618013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance evaluation of the Panbio COVID-19/Flu A&B Panel for detection of SARS-CoV-2, influenza A, and influenza B antigens using mid-turbinate nasal swabs.
    Yu S-H; Kim K-J; Lee C-C; Puebla YP; Zabat GMA; Shih H-M; Hsueh P-R
    J Clin Microbiol; 2024 Jul; 62(7):e0020724. PubMed ID: 38888305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of an immunochromatography-based rapid antigen test, Inspecter Kowa® SARS-CoV-2, using saliva specimens for the detection of SARS-CoV-2.
    Kodana M; Orihara Y; Tezuka M; Takahashi R; Noguchi S; Matsuzaki N; Takada T; Kobari N; Ogane K; Kawamura R; Kawamura T; Takeuchi S; Kamiyama Y; Shiomi R; Aoyagi R; Saito M; Kusano T; Nakaya N; Kaneko S; Morita H; Uchida Y; Yazawa H; Sekiya R; Katayama K; Mikami S; Sato T; Tarumoto N; Kobayashi T; Nakamoto H; Maeda T
    J Infect Chemother; 2023 Jun; 29(6):586-591. PubMed ID: 36849098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen rapid tests, nasopharyngeal PCR and saliva PCR to detect SARS-CoV-2: A prospective comparative clinical trial.
    Schwob JM; Miauton A; Petrovic D; Perdrix J; Senn N; Gouveia A; Jaton K; Opota O; Maillard A; Minghelli G; Cornuz J; Greub G; Genton B; D'Acremont V
    PLoS One; 2023; 18(2):e0282150. PubMed ID: 36827328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of storage temperatures simulating transport conditions of nasopharyngeal swabs on the results of a chemiluminescence immunoassay (CLIA) to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen.
    Kanta P; Ghosh A; Goyal K; Kaur R; Baluni M; Sircar S; Kumar V; Kumar K; Vijay N; Singh MP
    Indian J Med Microbiol; 2023; 44():100379. PubMed ID: 37356827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of a novel antigen detection test with reverse transcription polymerase chain reaction assay for laboratory diagnosis of SARS-CoV-2 infection.
    Cirit OS; Mutlu E; Sancak B; Kocagöz T; Can Ö; Çicek C; Arzu Sayiner A; Appak Ö; Uyar NY; Külah C; Çiçek AÇ; Özgümüs OB; Ay Altintop Y; Saatçi E; Karsligil T; Zer Y; Özen NS; Çekin Y; Karahan ZC; Evren E; Karakoç AE; Orhan SG; Mutlu D; Bozdemir T; Çayci YT; Çinar C; Tasbakan M; Mert M; Çinar E; Kutsoylu OÖE; Kocagöz S; Ertürk A; Çelik I; Mete AÖ; Günalp Eneyli M; Akdemir I; Karakök T; Inan D; Atilla A; Taflan ŞO; Yörük KE
    Infection; 2023 Feb; 51(1):91-96. PubMed ID: 35513690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus.
    Nordgren J; Sharma S; Olsson H; Jämtberg M; Falkeborn T; Svensson L; Hagbom M
    J Clin Virol; 2021 Jul; 140():104846. PubMed ID: 33971580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Abbott Panbio
    Shaw JLV; Deslandes V; Smith J; Desjardins M
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115514. PubMed ID: 34418823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative SARS-CoV-2 Viral-Load Curves in Paired Saliva Samples and Nasal Swabs Inform Appropriate Respiratory Sampling Site and Analytical Test Sensitivity Required for Earliest Viral Detection.
    Savela ES; Viloria Winnett A; Romano AE; Porter MK; Shelby N; Akana R; Ji J; Cooper MM; Schlenker NW; Reyes JA; Carter AM; Barlow JT; Tognazzini C; Feaster M; Goh YY; Ismagilov RF
    J Clin Microbiol; 2022 Feb; 60(2):e0178521. PubMed ID: 34911366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pooled Saliva Specimens for SARS-CoV-2 Testing.
    Barat B; Das S; De Giorgi V; Henderson DK; Kopka S; Lau AF; Miller T; Moriarty T; Palmore TN; Sawney S; Spalding C; Tanjutco P; Wortmann G; Zelazny AM; Frank KM
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33262219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations.
    Ptasinska A; Whalley C; Bosworth A; Poxon C; Bryer C; Machin N; Grippon S; Wise EL; Armson B; Howson ELA; Goring A; Snell G; Forster J; Mattocks C; Frampton S; Anderson R; Cleary D; Parker J; Boukas K; Graham N; Cellura D; Garratt E; Skilton R; Sheldon H; Collins A; Ahmad N; Friar S; Burns D; Williams T; Godfrey KM; Deans Z; Douglas A; Hill S; Kidd M; Porter D; Kidd SP; Cortes NJ; Fowler V; Williams T; Richter A; Beggs AD
    Clin Microbiol Infect; 2021 Sep; 27(9):1348.e1-1348.e7. PubMed ID: 33901668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified streptavidin-biotin based lateral flow test strip for rapid detection of SARS-CoV-2 S1 antigen in saliva samples.
    Kamel M; Atta S; Maher S; Abd Elaziz H; Demerdash Z
    Sci Rep; 2024 Mar; 14(1):7319. PubMed ID: 38538635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study.
    Corman VM; Haage VC; Bleicker T; Schmidt ML; Mühlemann B; Zuchowski M; Jo WK; Tscheak P; Möncke-Buchner E; Müller MA; Krumbholz A; Drexler JF; Drosten C
    Lancet Microbe; 2021 Jul; 2(7):e311-e319. PubMed ID: 33846704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of Self-Collected Saliva Testing Compared with Nasopharyngeal Swab Testing for the Detection of SARS-CoV-2.
    Carrouel F; Valette M; Perrier H; Bouscambert-Duchamp M; Dussart C; Tramini P; Bourgeois D
    Viruses; 2021 May; 13(5):. PubMed ID: 34066046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of SARS-CoV-2 antigen electrochemiluminescence immunoassay to RT-PCR assay for laboratory diagnosis of COVID-19 in Peshawar.
    Iqbal B; Khan M; Shah N; Dawood MM; Jehanzeb V; Shafi M
    Diagnosis (Berl); 2022 Aug; 9(3):364-368. PubMed ID: 34455727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omicron Wave SARS-CoV-2 Diagnosis: Evaluation of Saliva, Anterior Nasal, and Nasopharyngeal Swab Samples.
    Migueres M; Mansuy JM; Vasseur S; Claverie N; Lougarre C; Soulier F; Trémeaux P; Izopet J
    Microbiol Spectr; 2022 Dec; 10(6):e0252122. PubMed ID: 36318040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective study of three saliva qualitative antigen testing kits for the detection of SARS-CoV-2 among mainly symptomatic patients in Japan.
    Terada N; Akashi Y; Takeuchi Y; Ueda A; Notake S; Nakamura K; Suzuki H
    J Infect Chemother; 2023 Jul; 29(7):654-659. PubMed ID: 36894015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.